Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco

The viral haemorrhagic septicaemia virus (VHSV) causes high mortality in many marine and freshwater fish species, resulting in heavy economic losses in fish farming. Previously, cholera toxin B subunit (CTB)-fused recombinant viral haemorrhagic septicaemia virus glycoproteins (rec-VHSV-GPs) have bee...

Full description

Bibliographic Details
Main Authors: Tae Geum Kim, Bong Jo Kang, Sang Ik Park, Tae Jung Kim
Format: Article
Language:English
Published: Czech Academy of Agricultural Sciences 2019-10-01
Series:Veterinární Medicína
Subjects:
Online Access:https://vetmed.agriculturejournals.cz/artkey/vet-201910-0005_development-of-an-oral-vaccine-using-recombinant-viral-haemorrhagic-septicaemia-virus-glycoproteins-produced-in.php
_version_ 1828006532228317184
author Tae Geum Kim
Bong Jo Kang
Sang Ik Park
Tae Jung Kim
author_facet Tae Geum Kim
Bong Jo Kang
Sang Ik Park
Tae Jung Kim
author_sort Tae Geum Kim
collection DOAJ
description The viral haemorrhagic septicaemia virus (VHSV) causes high mortality in many marine and freshwater fish species, resulting in heavy economic losses in fish farming. Previously, cholera toxin B subunit (CTB)-fused recombinant viral haemorrhagic septicaemia virus glycoproteins (rec-VHSV-GPs) have been successfully expressed in tobacco, Nicotiana benthamiana. Here, we evaluated the potential of rec-VHSV-GPs as an oral vaccine against a live viral challenge. After immunisation of mice and fish (olive flounder, Paralichthys olivaceous) with those antigenic proteins in a feed additive form, the antibody titres were increased statistically, especially in the primed groups (P < 0.0001) in both the mouse and fish. After the viral challenge under low water temperature culture conditions (below 18 °C), the immunised fish were protected successfully against the challenge, showing a significantly lower mortality rate (P < 0.05). This result suggests that this plant-based immunisation system could induce an effective immune response. It could be used as a candidate to develop an oral vaccine for fish.
first_indexed 2024-04-10T07:59:11Z
format Article
id doaj.art-f865427e0534483e9e9926de235d6bde
institution Directory Open Access Journal
issn 0375-8427
1805-9392
language English
last_indexed 2024-04-10T07:59:11Z
publishDate 2019-10-01
publisher Czech Academy of Agricultural Sciences
record_format Article
series Veterinární Medicína
spelling doaj.art-f865427e0534483e9e9926de235d6bde2023-02-23T03:50:53ZengCzech Academy of Agricultural SciencesVeterinární Medicína0375-84271805-93922019-10-01641045646110.17221/26/2019-VETMEDvet-201910-0005Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobaccoTae Geum Kim0Bong Jo Kang1Sang Ik Park2Tae Jung Kim3Center for Jeongup Industry-Academy-Institute Cooperation, Chonbuk National University, Jeollabuk-do, Republic of KoreaOcean and Fisheries Research Institute, Jeju special self-governing province, Republic of KoreaCollege of Veterinary Medicine, Chonnam National University, Gwangju, Republic of KoreaCollege of Veterinary Medicine, Chonnam National University, Gwangju, Republic of KoreaThe viral haemorrhagic septicaemia virus (VHSV) causes high mortality in many marine and freshwater fish species, resulting in heavy economic losses in fish farming. Previously, cholera toxin B subunit (CTB)-fused recombinant viral haemorrhagic septicaemia virus glycoproteins (rec-VHSV-GPs) have been successfully expressed in tobacco, Nicotiana benthamiana. Here, we evaluated the potential of rec-VHSV-GPs as an oral vaccine against a live viral challenge. After immunisation of mice and fish (olive flounder, Paralichthys olivaceous) with those antigenic proteins in a feed additive form, the antibody titres were increased statistically, especially in the primed groups (P < 0.0001) in both the mouse and fish. After the viral challenge under low water temperature culture conditions (below 18 °C), the immunised fish were protected successfully against the challenge, showing a significantly lower mortality rate (P < 0.05). This result suggests that this plant-based immunisation system could induce an effective immune response. It could be used as a candidate to develop an oral vaccine for fish.https://vetmed.agriculturejournals.cz/artkey/vet-201910-0005_development-of-an-oral-vaccine-using-recombinant-viral-haemorrhagic-septicaemia-virus-glycoproteins-produced-in.phpflounderoral vaccineplant expressionviral haemorrhagic septicaemia virus
spellingShingle Tae Geum Kim
Bong Jo Kang
Sang Ik Park
Tae Jung Kim
Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco
Veterinární Medicína
flounder
oral vaccine
plant expression
viral haemorrhagic septicaemia virus
title Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco
title_full Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco
title_fullStr Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco
title_full_unstemmed Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco
title_short Development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco
title_sort development of an oral vaccine using recombinant viral haemorrhagic septicaemia virus glycoproteins produced in tobacco
topic flounder
oral vaccine
plant expression
viral haemorrhagic septicaemia virus
url https://vetmed.agriculturejournals.cz/artkey/vet-201910-0005_development-of-an-oral-vaccine-using-recombinant-viral-haemorrhagic-septicaemia-virus-glycoproteins-produced-in.php
work_keys_str_mv AT taegeumkim developmentofanoralvaccineusingrecombinantviralhaemorrhagicsepticaemiavirusglycoproteinsproducedintobacco
AT bongjokang developmentofanoralvaccineusingrecombinantviralhaemorrhagicsepticaemiavirusglycoproteinsproducedintobacco
AT sangikpark developmentofanoralvaccineusingrecombinantviralhaemorrhagicsepticaemiavirusglycoproteinsproducedintobacco
AT taejungkim developmentofanoralvaccineusingrecombinantviralhaemorrhagicsepticaemiavirusglycoproteinsproducedintobacco